VistaGen Therapeutics, Inc.VistaGen Therapeutics, Inc.VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc.

Inga transaktioner
Se i superdiagram

VTGN fundamenta

VistaGen Therapeutics, Inc. earnings per share and revenue

VTGN earnings per share for the last quarter are -0.22 USD whereas the estimation was -0.30 USD which accounts for 27.27% surprise. Företagets omsättning för samma period uppgår till 411.40 k USD trots den uppskattade siffran 726.00 k USD. Estimated earnings per share for the next quarter are -0.36 USD, and revenue is expected to reach 405.70 k USD. Also watch annual changes over time to get a bigger picture of VTGN earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
Utdelning per andel
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning
Omsättning
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning